Takeda Ventures
Investor profile
Corporate VC
Deals
8
distinct rounds
Companies
6
backed
Active span
2005–2025
21 yrs
Total round €
€78M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- AdBio partners1
- Advent France Biotechnology1
- CDTI Innvierte1
- Columbus Venture Partners1
- Demcon Investment1
- Dutch Government1
- EIC Fund1
- Essex Woodlands Health Ventures1
- Gilde Healthcare1
- i&i Biotech Fund1
- Innovation SBI Japan-Israel Innovation Fund1
- Invivo Capita I1
- Invivo Capital Partners1
- Johnson & Johnson1
- Mirae Asset Venture Investment1
- Novalis Biotech1
- Novo A1
- Oost NL1
- OrbiMed1
- S1
- Seventure Partners1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Symphogen | Denmark | 1 | €23M |
| BiomX | Israel | 1 | €22M |
| Integra Therapeutics | Spain | 2 | €15M |
| Enzyre | Netherlands | 1 | €12M |
| Univercells | Belgium | 2 | €6.0M |
| Zelluna Immunotherapy | Norway | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Symphogen | Series D+ | €23M | 2005-12 |
| BiomX | Series A | €22M | 2017-05 |
| Enzyre | Series A | €12M | 2022-11 |
| Integra Therapeutics | Seed | €11M | 2025-09 |
| Integra Therapeutics | Other | €4.5M | 2021-12 |
| Univercells | Other | €3.0M | 2017-03 |
| Univercells | Early VC | €3.0M | 2015-09 |